To reduce the risk of hyperactivity in pediatric sufferers, get started at one-fourth the recommended complete replacement dose, and increase with a weekly basis by 1-fourth the entire advisable replacement dose until eventually the total advisable replacement dose is arrived at. Management of artificial cathinone-induced toxicity is principally